Project Details
Description
An Open-Label, Long-Term Safety Study of SD-809 (Dutetravenazine) for the Treatment of Moderate to Severe Tardive Dyskinesia
| Status | Finished |
|---|---|
| Effective start/end date | 6/1/14 → 6/30/16 |
Funding
- AUSPEX PHARMACEUTICALS, INC
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.